Bank of New York Mellon Corp Has $27.12 Million Holdings in Azenta, Inc. (NASDAQ:AZTA)

Bank of New York Mellon Corp lifted its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 3.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 515,393 shares of the company’s stock after buying an additional 18,680 shares during the quarter. Bank of New York Mellon Corp owned about 0.96% of Azenta worth $27,120,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of AZTA. Principal Securities Inc. acquired a new stake in shares of Azenta during the fourth quarter worth $36,000. Benjamin F. Edwards & Company Inc. bought a new position in Azenta during the first quarter worth $38,000. Northwest Financial Advisors bought a new position in Azenta during the fourth quarter worth $46,000. BI Asset Management Fondsmaeglerselskab A S bought a new position in Azenta during the first quarter worth $49,000. Finally, Lazard Asset Management LLC bought a new position in Azenta during the first quarter worth $130,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Trading Down 1.3 %

Azenta stock opened at $47.25 on Thursday. Azenta, Inc. has a 1-year low of $44.00 and a 1-year high of $69.16. The firm has a market capitalization of $2.55 billion, a price-to-earnings ratio of -17.44 and a beta of 1.51. The firm’s fifty day moving average price is $53.38 and its two-hundred day moving average price is $55.35.

Azenta (NASDAQ:AZTA) last released its quarterly earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.09. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. The company had revenue of $173.00 million for the quarter, compared to analyst estimates of $166.14 million. During the same period last year, the firm earned $0.13 earnings per share. The firm’s revenue was up 4.2% on a year-over-year basis. On average, research analysts forecast that Azenta, Inc. will post 0.32 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Needham & Company LLC reissued a “buy” rating and set a $69.00 target price on shares of Azenta in a research note on Wednesday, August 7th. Evercore ISI increased their target price on shares of Azenta from $52.00 to $53.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 2nd. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $67.00.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.